• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    8/22/24 6:39:55 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials
    Get the next $OWLT alert in real time by email
    SC 13D/A 1 d883289dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 4)

     

     

    OWLET, INC.

    (Name of Issuer)

    Class A Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

    69120X206

    (CUSIP Number)

    Lior Susan

    Managing Member

    Eclipse Ventures

    514 High Street, Suite 4

    Palo Alto, CA 94301

    (650) 720-4667

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    August 20, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on following pages)

     

     

     


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Eclipse Continuity GP I, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     0

        8  

     SHARED VOTING POWER

     

     1,066,472 (1)

        9  

     SOLE DISPOSITIVE POWER

     

     0

       10  

     SHARED DISPOSITIVE POWER

     

     1,066,472 (1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     1,066,472 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     9.1% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     OO

     

    (1)

    All shares are held by Eclipse Continuity I (as defined in Item 2(a) of the Original Schedule 13D, as defined below). Eclipse Continuity GP (as defined in Item 2(a) of the Original Schedule 13D) is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Lior Susan, a member of the Issuer’s board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power with respect to these securities.

    (2)

    Based on 11,710,310 shares of the Issuer’s (as defined in the Explanatory Note below) Class A Common Stock (as defined in the Explanatory Note below) outstanding following the Conversion (as defined in Item 4 below), as reported by the Issuer in its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “Commission”) on August 22, 2024 (the “Form 8-K”).


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Eclipse Continuity Fund I, L.P.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     WC

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     0

        8  

     SHARED VOTING POWER

     

     1,066,472 (1)

        9  

     SOLE DISPOSITIVE POWER

     

     0

       10  

     SHARED DISPOSITIVE POWER

     

     1,066,472 (1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     1,066,472 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     9.1% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     PN

     

    (1)

    All shares are held by Eclipse Continuity I. Eclipse Continuity GP is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Lior Susan, a member of the Issuer’s board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power with respect to these securities.

    (2)

    Based on 11,710,310 shares of the Issuer’s Class A Common Stock outstanding following the Conversion, as reported by the Issuer in its Form 8-K.


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Eclipse Ventures GP I, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     0

        8  

     SHARED VOTING POWER

     

     968,694 (1)

        9  

     SOLE DISPOSITIVE POWER

     

     0

       10  

     SHARED DISPOSITIVE POWER

     

     968,694 (1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     968,694 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     8.3% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     OO

     

    (1)

    All shares are held by Eclipse I (as defined in Item 2(a) of the Original Schedule 13D). Eclipse I GP (as defined in Item 2(a) of the Original Schedule 13D) is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Lior Susan, a member of the Issuer’s board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power with respect to these securities.

    (2)

    Based on 11,710,310 shares of the Issuer’s Class A Common Stock outstanding following the Conversion, as reported by the Issuer in its Form 8-K


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Eclipse Ventures Fund I, L.P.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     WC

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     0

        8  

     SHARED VOTING POWER

     

     968,694 (1)

        9  

     SOLE DISPOSITIVE POWER

     

     0

       10  

     SHARED DISPOSITIVE POWER

     

     968,694 (1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     968,694 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     8.3% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     PN

     

    (1)

    All shares are held by Eclipse I. Eclipse I GP is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Lior Susan, a member of the Issuer’s board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power with respect to these securities.

    (2)

    Based on 11,710,310 shares of the Issuer’s Class A Common Stock outstanding following the Conversion, as reported by the Issuer in its Form 8-K.


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Eclipse Early Growth GP I, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     0

        8  

     SHARED VOTING POWER

     

     5,532,735 (1)

        9  

     SOLE DISPOSITIVE POWER

     

     0

       10  

     SHARED DISPOSITIVE POWER

     

     5,532,735 (1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     5,532,735 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     35.7% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     OO

     

    (1)

    These securities are held by Eclipse EGF I and consist of (i) 1,766,763 shares of Class A Common Stock, plus (ii) an aggregate of 3,765,972 shares of Class A Common Stock issuable upon conversion of shares of Series A Convertible Preferred Stock (as defined in Item 6 of the Original Schedule 13D) and/or Series B Convertible Preferred Stock (as defined in Item 6 of the Original Schedule 13D) and/or upon exercise of the Warrants (as defined in Item 6 of the Original Schedule 13D). This total excludes an aggregate of 4,657,083 shares of Class A Common Stock issuable upon the conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants (as defined in Item 6 of the Original Schedule 13D) held by Eclipse EGF I as a result of the 2024 Individual Holder Share Cap (as defined in Item 6 of the Original Schedule 13D). Eclipse EG GP I (as defined in Item 2(a) of the Original Schedule 13D) is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power with respect to these securities.

    (2)

    Based on (i) 11,710,310 shares of the Issuer’s Class A Common Stock outstanding following the Conversion, as reported by the Issuer in its Form 8-K, plus (ii) the issuance of an aggregate of 3,765,972 shares of Class A Common Stock upon the conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants held by Eclipse EGF I.


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Eclipse Early Growth Fund I, L.P.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     WC

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     0

        8  

     SHARED VOTING POWER

     

     5,532,735 (1)

        9  

     SOLE DISPOSITIVE POWER

     

     0

       10  

     SHARED DISPOSITIVE POWER

     

     5,532,735 (1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     5,532,735 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     35.7% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     PN

     

    (1)

    These securities are held by Eclipse EGF I and consist of (i) 1,766,763 shares of Class A Common Stock, plus (ii) an aggregate of 3,765,972 shares of Class A Common Stock issuable upon conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock and/or upon exercise of the Warrants. This total excludes an aggregate of 4,657,083 shares of Class A Common Stock issuable upon the conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants held by Eclipse EGF I as a result of the 2024 Individual Holder Share Cap. Eclipse EG GP I is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power with respect to these securities.

    (2)

    Based on (i) 11,710,310 shares of the Issuer’s Class A Common Stock outstanding following the Conversion, as reported by the Issuer in its Form 8-K, plus (ii) the issuance of an aggregate of 3,765,972 shares of Class A Common Stock upon the conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants held by Eclipse EGF I.


    CUSIP No. 69120X206    13D

     

     1   

     NAMES OF REPORTING PERSONS

     

     Lior Susan

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (see instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

     7,567,901 (1)

        8  

     SHARED VOTING POWER

     

     0

        9  

     SOLE DISPOSITIVE POWER

     

     7,567,901 (1)

       10  

     SHARED DISPOSITIVE POWER

     

     0

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     7,567,901 (1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

     48.9% (1) (2)

    14  

     TYPE OF REPORTING PERSON (see instructions)

     

     IN

     

    (1)

    Consists of (i) 1,066,472 shares of Class A Common Stock held by Eclipse Continuity I, (ii) 968,694 shares of Class A Common Stock held by Eclipse I, (iii) 1,766,763 shares of Class A Common Stock held by Eclipse EGF I and (iv) an aggregate of 3,765,972 shares of Class A Common Stock issuable upon conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants held by Eclipse EGF I. This total excludes an aggregate of 4,657,083 shares of Class A Common Stock issuable upon the conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants held by Eclipse EGF I as a result of the 2024 Individual Holder Share Cap. Eclipse Continuity GP is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse I GP is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse EG GP I is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of each of Eclipse Continuity GP, Eclipse I GP and Eclipse EG GP I and may be deemed to have voting and dispositive power with respect to the shares held by each of Eclipse Continuity I, Eclipse I and Eclipse EGF I.

    (2)

    Based on (i) 11,710,310 shares of the Issuer’s Class A Common Stock outstanding following the Conversion, as reported by the Issuer in its Form 8-K, plus (ii) the issuance of an aggregate of 3,765,972 shares of Class A Common Stock upon the conversion of shares of Series A Convertible Preferred Stock and/or Series B Convertible Preferred Stock held by Eclipse EGF I and/or upon exercise of the Warrants held by Eclipse EGF I


    CUSIP No. 69120X206    13D

     

    Explanatory Note:

    This joint statement on Schedule 13D/A (this “Statement”) is filed with respect to the Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of Owlet, Inc., a Delaware corporation (the “Issuer”). This Amendment No. 3 supplements and amends the Schedule 13D relating to the Class A Common Stock of the Issuer that was filed with the Commission on July 26, 2021, as amended by Amendment No. 1 filed with the Commission on February 27, 2023, Amendment No. 2 filed with the Commission on February 8, 2024 and Amendment No. 3 filed with the Commission on March 4, 2024 (the “Original Schedule 13D”). Only those items that are reported are hereby amended; all other items reported in the Original Schedule 13D remain unchanged. Capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items as applicable.

    Item 4. Purpose of Transaction.

    On August 20, 2024, Eclipse EGF I converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Series B Certificate of Designation, into an aggregate of 1,766,763 shares of Class A Common Stock (the “Conversion”). Except as set forth above, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of the Original Schedule 13D.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: August 22, 2024

     

    ECLIPSE VENTURES FUND I, L.P.
    By:   Eclipse Ventures GP I, LLC
    Its:   General Partner
    By:  

    /s/ Lior Susan

      Lior Susan
    Its:   Managing Member
    ECLIPSE VENTURES GP I, LLC
    By:  

    /s/ Lior Susan

      Lior Susan
    Its:   Managing Member
    ECLIPSE CONTINUITY FUND I, L.P.
    By:   Eclipse Continuity GP I, LLC
    Its:   General Partner
    By:  

    /s/ Lior Susan

      Lior Susan
    Its:   Managing Member
    ECLIPSE CONTINUITY GP I, LLC
    By:  

    /s/ Lior Susan

      Lior Susan
    Its:   Managing Member


    ECLIPSE EARLY GROWTH FUND I, L.P.
    By:   Eclipse Early Growth GP I, LLC
    Its:   General Partner
    By:  

    /s/ Lior Susan

      Lior Susan
    Its:   Managing Member
    ECLIPSE EARLY GROWTH GP I, LLC
    By:  

    /s/ Lior Susan

      Lior Susan
    Its:   Managing Member
     

    /s/ Lior Susan

      Lior Susan
    Get the next $OWLT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OWLT

    DatePrice TargetRatingAnalyst
    4/23/2025$7.00Outperform
    Northland Capital
    10/6/2021$12.00 → $5.00Neutral
    Citigroup
    10/5/2021$8.50 → $5.50Buy → Neutral
    BofA Securities
    9/8/2021$8.50Buy
    BofA Securities
    8/5/2021$11.00Neutral
    Citigroup
    More analyst ratings

    $OWLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Owlet Inc.

      SC 13G/A - Owlet, Inc. (0001816708) (Subject)

      10/24/24 4:05:58 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Owlet Inc.

      SC 13D/A - Owlet, Inc. (0001816708) (Subject)

      8/22/24 6:39:55 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Owlet Inc.

      SC 13D/A - Owlet, Inc. (0001816708) (Subject)

      8/22/24 4:25:26 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials

    $OWLT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Owlet Announces First Quarter 2025 Financial Results

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, May 8, 2025, at 4:30 p.m. ET. Q1 2025 Financial Highlights: Q1 Revenue of $21.1 million, up 43.1% from Q1 2024 Q1 Gross Margin of 53.7%, up 930 basis points from Q1 2024 Q1 Net Income of $3.0 million, compared to $3.3 million in Q1 2024 Q1 Adjusted EBITDA of $0.0 million, improving

      5/8/25 4:05:00 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet to Report First Quarter 2025 Financial Results on May 8, 2025

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) plans to announce first quarter 2025 financial results after market close on Thursday, May 8, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 952382. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay will be available on th

      4/24/25 4:05:00 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet Announces Fourth Quarter and Full Year 2024 Results

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, March 4, 2025, at 4:30 p.m. ET. Q4 2024 Financial Highlights Q4 Revenue of $20.5 million, compared to $21.0 million in Q4 2023. Excluding the revenue impact from the prior year Amazon distribution partner transition, which shifted $6 million of

      3/4/25 4:06:00 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials

    $OWLT
    Financials

    Live finance-specific insights

    See more
    • Owlet Announces First Quarter 2025 Financial Results

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, May 8, 2025, at 4:30 p.m. ET. Q1 2025 Financial Highlights: Q1 Revenue of $21.1 million, up 43.1% from Q1 2024 Q1 Gross Margin of 53.7%, up 930 basis points from Q1 2024 Q1 Net Income of $3.0 million, compared to $3.3 million in Q1 2024 Q1 Adjusted EBITDA of $0.0 million, improving

      5/8/25 4:05:00 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet to Report First Quarter 2025 Financial Results on May 8, 2025

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) plans to announce first quarter 2025 financial results after market close on Thursday, May 8, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 952382. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay will be available on th

      4/24/25 4:05:00 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet Announces Fourth Quarter and Full Year 2024 Results

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, March 4, 2025, at 4:30 p.m. ET. Q4 2024 Financial Highlights Q4 Revenue of $20.5 million, compared to $21.0 million in Q4 2023. Excluding the revenue impact from the prior year Amazon distribution partner transition, which shifted $6 million of

      3/4/25 4:06:00 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials

    $OWLT
    Leadership Updates

    Live Leadership Updates

    See more
    • Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m

      10/2/23 8:30:00 AM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors

      Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome

      8/16/23 9:00:00 AM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

      Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'

      7/19/23 9:00:00 AM ET
      $OWLT
      Industrial Machinery/Components
      Industrials

    $OWLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Harris Jonathan sold $56,606 worth of shares (14,170 units at $3.99), decreasing direct ownership by 5% to 266,707 units (SEC Form 4)

      4 - Owlet, Inc. (0001816708) (Issuer)

      5/21/25 9:15:54 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Crawford Amanda sold $783 worth of shares (182 units at $4.30), decreasing direct ownership by 0.12% to 150,508 units (SEC Form 4)

      4 - Owlet, Inc. (0001816708) (Issuer)

      1/21/25 9:30:13 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • President & CRO Harris Jonathan sold $106,436 worth of shares (24,179 units at $4.40), decreasing direct ownership by 8% to 280,877 units (SEC Form 4)

      4 - Owlet, Inc. (0001816708) (Issuer)

      1/21/25 9:24:43 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials

    $OWLT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Owlet Inc.

      10-Q - Owlet, Inc. (0001816708) (Filer)

      5/8/25 5:06:34 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Owlet, Inc. (0001816708) (Filer)

      5/8/25 4:06:41 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form 10-K/A filed by Owlet Inc.

      10-K/A - Owlet, Inc. (0001816708) (Filer)

      4/30/25 4:55:03 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials

    $OWLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Northland Capital initiated coverage on Owlet with a new price target

      Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00

      4/23/25 9:11:45 AM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Citigroup reiterated coverage on Owlet with a new price target

      Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously

      10/6/21 12:45:24 PM ET
      $OWLT
      Industrial Machinery/Components
      Industrials
    • Owlet downgraded by BofA Securities with a new price target

      BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously

      10/5/21 7:41:47 AM ET
      $OWLT
      Industrial Machinery/Components
      Industrials